Clinical Trial Update: A Study of BLB-201 RSV Vaccine in Infants and Children [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating BLB-201 RSV vaccine in infants and children is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• BLB-201 RSV Vaccine (BLB-201 RSV vaccine)

Snippet

Sponsor: Blue Lake Biotechnology Inc. | Conditions: Respiratory Syncytial Virus Infections | Phase 1, Phase 2 | Status: RECRUITING